Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis

Use of anti-B-cell therapy in case of antisynthetase syndrome as the severest subtype of polymyositis/dermatomyositis

Antisynthetase syndrome encompassing a symptom complex with severe interstitial lung disease is the severest subtype of polymyositis and dermatomyositis. The characteristic feature of antisynthetase syndrome is the insufficient efficiency of traditional therapy with glucocorticosteroids and cytostat...

Full description

Bibliographic Details
Main Authors: O A Antelava, A N Khelkovskaia-Sergeeva, G M Tarasova, N Iu Nikishina, N E Lopatina, S G Pal'shina, T P Fedina, E G Sazhina
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2014-05-01
Series:Терапевтический архив
Subjects:
polymyositis
dermatomyositis
antisynthetase syndrome
rituximab
interstitial lung disease
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31534

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31534

Similar Items